Authors:
COLE BF
SOLALCELIGNY P
GELBER RD
LEPAGE E
GISSELBRECHT C
REYES F
SEBBAN C
SUGANO D
TENDLER C
GOLDHIRSCH A
Citation: Bf. Cole et al., QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING, Journal of clinical oncology, 16(7), 1998, pp. 2339-2344
Citation: H. Ozer et al., RECOMBINANT INTERFERON-ALPHA THERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA (VOL 82, PG 1821, 1998), Cancer, 83(3), 1998, pp. 593-593
Citation: H. Ozer et al., INTEGRATED ANALYSIS OF THE SAFETY AND EFFICACY OF CONCURRENT THERAPY WITH RIFN-ALPHA AND CHEMOTHERAPY IN FOLLICULAR NHL, Blood, 90(10), 1997, pp. 3933-3933
Authors:
SOLALCELIGNY P
LEPAGE E
BROUSSE N
TERTIAN G
THYSS A
REMAN O
SEBBAN C
PIGNON B
GISSELBRECHT C
COIFFIER B
COLE B
SUGANO D
TENDLER C
Citation: P. Solalceligny et al., A DOXORUBICIN CONTAINING REGIMEN WITH OR WITHOUT INTERFERON-ALPHA-2B (IFN-ALPHA 2B) IN ADVANCED FOLLICULAR LYMPHOMAS - FINAL ANALYSIS OF SURVIVAL, TOXICITY AND QUALITY-OF-LIFE OF THE GELF86 TRIAL, Blood, 88(10), 1996, pp. 1800-1800
Authors:
PIZZOLATO J
GREENBERG D
STREETER G
MANFREDI J
LACKNER C
ARKIN S
TENDLER C
Citation: J. Pizzolato et al., P53 STATUS IN AIDS LYMPHOMA CELL-LINES CORRELATES WITH SENSITIVITY TOCHEMOTHERAPY AND RADIATION-INDUCED APOPTOSIS, Blood, 86(10), 1995, pp. 2943-2943